January 05, 2021

Revolution Medicines

Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference

January 05, 2021

Rhythm Pharmaceuticals

Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M

January 04, 2021

Pliant Therapeutics

Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF

December 22, 2020

Voyager Therapeutics

Voyager Therapeutics Provides Update On NBIb-1817 (VY-AADC) Gene Therapy Program

December 22, 2020

CytomX Therapeutics

CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors

Load More

Sign up for weekly portfolio news.